Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
2.050
+0.020 (0.99%)
At close: Mar 27, 2025

EGX:MCRO Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,1411,3231,6821,870--
Market Cap Growth
-21.36%-21.36%-10.06%---
Enterprise Value
1,3951,4751,8151,944--
Last Close Price
2.032.322.953.18--
PE Ratio
---10.76--
Forward PE
-10.0710.0710.07--
PS Ratio
2.232.543.202.56--
PB Ratio
14.6416.9417.834.04--
P/TBV Ratio
25.8425.8425.104.56--
P/FCF Ratio
--14.43--
P/OCF Ratio
--13.86--
PEG Ratio
0.420.420.420.42--
EV/Sales Ratio
2.682.843.452.66--
EV/EBITDA Ratio
48.8088.83-8.17--
EV/EBIT Ratio
115.97122.57-8.30--
EV/FCF Ratio
-16.08--15.00--
Debt / Equity Ratio
4.054.052.400.440.270.26
Debt / EBITDA Ratio
11.0611.06-0.830.470.35
Debt / FCF Ratio
---1.582.201.64
Asset Turnover
0.920.920.771.021.21-
Inventory Turnover
1.611.611.641.642.15-
Quick Ratio
0.360.360.291.181.191.18
Current Ratio
1.351.351.082.002.312.06
Return on Equity (ROE)
-44.13%-44.13%-97.85%42.37%48.77%-
Return on Assets (ROA)
1.33%1.33%-16.72%20.53%25.81%-
Return on Capital (ROIC)
2.10%2.10%-23.07%26.08%33.12%-
Return on Capital Employed (ROCE)
5.20%5.20%-48.50%54.90%72.40%
Earnings Yield
-3.34%-2.88%-16.21%9.29%--
FCF Yield
-7.60%-6.56%-2.64%6.93%--
Dividend Yield
0.00%--3.36%--
Payout Ratio
0.00%--23.01%31.65%54.65%
Buyback Yield / Dilution
-1.12%-1.12%1.46%0.88%--
Total Shareholder Return
-1.12%-1.12%1.46%4.24%--
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.